Lindsey Allen

Bio:

Named PRWeek’s 2023 Outstanding In-House Professional, Lindsey Allen is a corporate communications and investor relations executive with more than a decade of experience helping biopharmaceutical companies convey their science and strategy with key stakeholders worldwide. As Vice President of Investor Relations & Communications at Amylyx Pharmaceuticals, Lindsey serves as corporate steward of the company, responsible for driving corporate reputation and leading global efforts to share the company’s mission, values, scientific innovation, and strategy.

Throughout her career, Lindsey has been at the forefront of transformative moments in biotech, including developing post-IPO investor relations and communications strategies to establish a clear value narrative, guiding communications for pivotal clinical milestones, and advancing patient-centered engagement. She previously held a senior leadership role at Corbus Pharmaceuticals, where she built the corporate communications function, served as primary liaison with the Wall Street community, and helped raise $150M+ in equity capital. Earlier in her career at Alkermes, she drove product and internal communications, corporate media relations, and launched the company’s digital strategy.

Lindsey graduated with honors from Ithaca College with a Bachelor of Science degree in Television Radio with a concentration in international communications and minors in economics and integrated marketing communications.